Allergan (NYSE:AGN) said today that it closed its $2.48 billion acquisition of Zeltiq Aesthetics Inc. (NSDQ:ZLTQ) and its portfolio of body-contouring products. Zeltiq’s FDA-approved CoolSculpting system uses a cooling mechanism to reduce the appearance of fat which has not responded to diet or exercise, without disturbing surrounding tissue. Get the full story at our sister […]
Allergan acquires Zeltiq Aesthetics in $2.48B deal
Allergan (NYSE:AGN) said today that it will pay $2.48 billion for Zeltiq Aesthetics Inc. (NSDQ:ZLTQ) and its portfolio of body-contouring products. Zeltiq’s FDA-approved CoolSculpting system uses a cooling mechanism to reduce the appearance of fat which has not responded to diet or exercise, without disturbing surrounding tissue. Get the full story at our sister site, Drug […]
HeartWare taps ex-Medtronic exec Oesterle for board | Personnel Moves
HeartWare International (NSDQ:HTWR) is looking to get in on Dr. Stephen Oesterle, an Ex-Medtronic (NYSE:MDT) exec who moved to the venture capital firm New Enterprise Associates last Sept., saying this week that it expanded its board to accommodate Oesterle. Oesterle will officially come aboard on Jan. 18, and his appointment included an expansion to HeartWare’s board […]
Spanish court denies Zeltiq, Mass. General in patent suit against Clinipro
Zeltiq (NSDQ:ZLTQ) said the Mercantile Court in Spain denied its bid for a preliminary injunction against Clinipro in a joint lawsuit filed with Mass. General Hospital against the French medical aesthetics company.
Zeltiq and MGH sued Clinipro last year in France and Spain, alleging infringement of 2 patents for its CoolSculpting device.
Accuray details new CEO appointment | Personnel Moves
Weight-loss: Zeltiq Aesthetics launches new CoolCurve applicator for “reducing fat bulges”
Zeltiq makes it official with interim CEO | Personnel Moves
By the numbers: The aesthetic medical device market picks up during the 2nd quarter
The market for aesthetic medical devices gained some ground during the 2nd quarter, a MassDevice.com analysis shows, although healthy sales growth didn’t necessarily translate into healthy bottom lines for all comers.
Mako Surgical shareholders file 6 lawsuits in 4 months after stock dives
Mako Surgical (NSDQ:MAKO) shareholders have filed 6 lawsuits in the last 4 months, accusing the company of misstating the company’s sales and financial outlook in order to artificially inflate its stock value.
University of Michigan sues St. Jude Medical for breach of contract
The University of Michigan is suing St. Jude Medical (NYSE:STJ), accusing the medical device maker of failing to pay $4.3 million in royalties on sales of St. Jude’s Epic and Trifecta cardiovascular valves.
MassDevice Network
@MassDevice
LinkedIn
YouTube